Research7h ago0 views

Establishing standardized evaluation protocols for peptide-target interaction prediction: the PTI-TAPE consensus framework eDelphi.

Peptide-target interaction (PTI) prediction just got a serious upgrade. The PTI-TAPE framework, hammered out by 15 experts across computational biology, machine learning, and regulatory science, aims to clean up the wild west of peptide research benchmarks. Until now, PTI studies used inconsistent metrics and scattershot datasets. That made it nearly impossible to compare results or trust that a promising peptide prediction would actually pan out in the real world.

Front Bioinform

by Waldock WJ, Wang G, Darzi A et al.

“Establishing standardized evaluation protocols for peptide-target interaction prediction: the PTI-TAPE consensus framework eDelphi. Waldock WJ(1), Wang G(2), Darzi A(1), de la Fuente-Nunez C(3)(4)(5)(6), Ashrafian H(1); PTI-TAPE Consortium Committee. Author information: (1)Imperial College London, Institute of Global Health Innovation, London, United Kingdom. (2)Department of Pathology, Microbiology, and Immunology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, United States. (3)Machine Biology Group, Departments of Psychiatry and Microbiology, Perelman School of Medicine, Institute for Biomedical Informatics, Institute for Translational Medicine and Therapeutics, University of Pennsylvania, Philadelphia, PA, United States. (4)Departments of Bioengineering and Chemical and Biomolecular Engineering, School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, PA, United States. (5)Department of Chemistry, School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, United States. (6)Penn Institute for Computational Science, University of Pennsylvania, Philadelphia, PA, United States. Computational peptide-target interaction (PTI) prediction has advanced rapidly as a tool for drug discovery, yet the field lacks agreed evaluation standards. Discrepancies in metrics, negative sampling strategies, and dataset construction across publications currently render cross-study comparisons methodologically intractable, ultimately impeding the clinical translation of therapeutic peptides. To resolve this, we present PTI-TAPE (Peptide-Target Interaction-Tasks Assessing Peptide Engagement), a standardised benchmarking framework developed via a structured three-round eDelphi consensus study with 15 international experts spanning computational biology, machine learning, and regulatory science. Operating under a robust consensus threshold (>80% agreement), the panel established 26 definitive standards across eight domains, governed by the new STRIDE (Standardisation, Transparency, Representativeness, Integration, Discovery, Evidence) framework. Key outcomes include mandating specific primary metrics for affinity and structure, enforcing a tiered negative sampling hierarchy that prioritizes experimental non-binders, and requiring mandatory temporal dataset splits. By providing a unified reporting checklist, benchmark specifications, and a biennial governance structure, PTI-TAPE ensures reproducible evaluation and fair method comparison, bridging the gap between computational PTI predictions and genuine therapeutic benefit. Copyright © 2026 Waldock, Wang, Darzi, de la Fuente-Nunez, Ashrafian and the PTI-TAPE Consortium Committee. PMCID: PMC13690808 Conflict of interest statement: CdF-N is a co-founder of and scientific advisor to Peptaris, Inc.; provides consulting services to Invaio Sciences; and serves on the Scientific Advisory Boards of Basecamp Research, Intera Bio, Nowture S.L., Peptidus, European Biotech Venture Builder, the Peptide Drug Hunting Consortium (PDHC), ePhective Therapeutics, Inc., and Phare Bio. The remaining author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.”

Now, with PTI-TAPE, there’s a clear playbook. The panel reached over 80% consensus on 26 standards across eight categories. The STRIDE framework (Standardisation, Transparency, Representativeness, Integration, Discovery, Evidence) forms the backbone of this new approach. Here’s what’s different:

•

Affinity and structure metrics are now standardized — no more apples-to-oranges comparisons.

•

Negative sampling isn’t a guessing game anymore. The framework enforces a tiered system, so experimental non-binders come first in test sets.

•

Datasets must be split by time, not just shuffled at random. This mirrors real-world research, where new data comes after the old.

Key takeaway: PTI-TAPE gives researchers a transparent checklist and a regular review process. Results should be reproducible, and future peptide prediction models can be compared on level ground. That means faster progress, less wasted effort, and a better shot at translating computational findings into therapeutic breakthroughs.

For anyone working with peptide-target predictions, these standards are about to become the new normal. Check out the peptide research index for more context on PTI and related developments. The era of “trust me, bro” PTI benchmarks is finally over.

Back to News Read original on Front Bioinform

Establishing standardized evaluation protocols for peptide-target interaction prediction: the PTI-TAPE consensus framework eDelphi.

Related Reading

[Application of cell-penetrating peptides in tumor therapy].

Reverse Micelles: The Gateway for Oral (Poly)Peptide Delivery.

Tirzepatide versus other glucose-lowering therapies and risk of COPD exacerbations in patients with comorbid type 2 diabetes: a retrospective cohort study.